Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Business Strategies

Baxter Spins Off Drug Business To Focus On Devices, Anesthesia & Nutrition Products

This article was originally published in The Gray Sheet

  • News

Executive Summary

Kidney dialysis and biosurgery will be two major focus points for a newly refined Baxter after it spins off its biopharmaceuticals business, as planned for mid-2015.

You may also be interested in...



Report: Baxter Considers Dropping Renal Care Businesses

Bloomberg reported that Baxter is exploring options to divest its renal care services and hemodialysis businesses to focus more resources on higher-growth businesses and pay down the debt it took on to acquire Hillrom last year.

Joe Almeida Tapped As CEO Of Baxter

Former Covidien CEO José (Joe) Almeida has been appointed CEO of Baxter as the company zeroes in on its device businesses.

People Briefs: JenaValve CEO; Ortho-Clinical Changes; Baxter CFOs

JenaValve Technology names David Drachman as CEO. Ortho-Clinical Diagnostics makes executive changes following split from J&J. Baxter plans a CFO switch when it completes its biopharmaceutical company spinoff next year. More people news.

Table

View full table

Related Content

Medtech Insight
Medtech Insight

Topics

Related Companies

Tags:
Medical Device Business Strategies
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT032857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By